Lanean...
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling
Epidermal Growth Factor Receptor (EGFR) gene amplification and mutations are the most common oncogenic events in Glioblastoma (GBM), but the mechanisms by which they promote aggressive tumor growth are not well understood. Here, through integrated epigenome and transcriptome analyses of cell lines,...
Gorde:
Argitaratua izan da: | Mol Cell |
---|---|
Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , |
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
2015
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4609298/ https://ncbi.nlm.nih.gov/pubmed/26455392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molcel.2015.09.002 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|